articleNature NanotechnologyFeb 3, 2025HYBRID OA

Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors

Eindhoven University of Technology · Radboud University Nijmegen · +10 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Nucleic acid therapeutics are used for silencing, expressing or editing genes in vivo. However, their systemic stability and targeted delivery to bone marrow resident cells remains a challenge. In this study we present a nanotechnology platform based on natural lipoproteins, designed for delivering small interfering RNA (siRNA), antisense oligonucleotides and messenger RNA to myeloid cells and haematopoietic stem and progenitor cells in the bone marrow. We developed a prototype apolipoprotein nanoparticle (aNP) that stably incorporates siRNA into its core. We then created a comprehensive library of aNP formulations and extensively characterized their physicochemical properties and in vitro performance. From…

No related works found for this paper.

Funding